MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

Stock Information for MiMedx Group Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MiMedx Group Inc

MIMEDX Announces First Quarter 2023 Operating and Financial Results
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer
MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics
MIMEDX to Present at Upcoming Investor Conferences
MIMEDX Announces Third Quarter 2022 Operating and Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.